Apium graveolens Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Umbelliferae; Apiaceae. |
| Habitat | Native to Europe; cultivated in northwestern Himalayas and in hills of Uttar Pradesh, Himachal Pradesh and southern India. |
| English | Celery. |
| Ayurvedic | Ajmodaa, Ajmoda, Ajmodikaa, Dipyaka. |
| Unani | Karafs. |
| Siddha / Tamil | Celery-keerai. |
| Folk | Ajmodaa. |
| Action | Anti-inflammatory (used in rheumatic disorders, inflammation of the urinary tract), diuretic, carminative, nervine, sedative, antiemetic, antispasmodic, antiseptic (used in bronchitis, asthma, as well as liver and spleen diseases), emmenagogue. Essential oil from seeds—tranquilizer, anticonvulsant, antifungal. Seeds are used in the treatment of chronic skin disorders including psoriasis. |
| Key Application | As diuretic. (The British Herbal Pharmacopoeia.) |
| Taxonomic Cohort | Genus Apium (2 documented species); Family Umbelliferae (42 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Apium graveolens (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Umbelliferae; Apiaceae (primary family classification: Umbelliferae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Native to Europe; cultivated in northwestern Himalayas and in hills of Uttar Pradesh, Himachal Pradesh and southern India.
Across classical and vernacular Indian systems of medicine, Apium graveolens is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Celery; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Ajmodaa, Ajmoda, Ajmodikaa, Dipyaka; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Karafs; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Celery-keerai; in regional Indian folk and vernacular ethnobotany as Ajmodaa. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Apium graveolens are: Anti-inflammatory (used in rheumatic disorders, inflammation of the urinary tract), diuretic, carminative, nervine, sedative, antiemetic, antispasmodic, antiseptic (used in bronchitis, asthma, as well as liver and spleen diseases), emmenagogue. Essential oil from seeds—tranquilizer, anticonvulsant, antifungal. Seeds are used in the treatment of chronic skin disorders including psoriasis. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: As diuretic. (The British Herbal Pharmacopoeia.).
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Apium graveolens establish the following evidence base: Celery yields an essential oil (3%), major constituent being d-limonene (50%) and phathalides and beta-selinene; coumarins, furanocoumarins (bergapten); flavonoids (apiin and apigenin). Alkaloid fraction of seeds showed tranquilizing activity in animals. The phthalides are sedative in mice and exhibit antiepileptic activity in rats and mice. The aqueous extract of the celery has been shown to reduce adjuvant-induced arthritis in rats, and to be hypotensive in patients as well as animals. The tincture of the plant exhibits drop in blood pressure accompanied by an increase in urine output.
In specialized pharmacognostic classifications, Apium graveolens is also listed among standardized commercial herbal extracts used in India with defined quantitative phytochemical markers; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

Figure 1: Authenticated crude herb specimen — Apium graveolens fruit.

Botanical Reference 1: Apium graveolens — Botanical specimen

Botanical Reference 2: Apium graveolens — Botanical specimen

Botanical Reference 3: Apium graveolens — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Apium comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Apium leptophyllum (Action: See Apium graveolens). Comparing Apium graveolens alongside its congeners in genus Apium highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Umbelliferae encompasses 42 documented medicinal species (2.32% of the 1,814-species flora). Other representative medicinal members of Umbelliferae include: Ammi majus (Biship’s Weed-Amee), Ammi visnaga (Khella), Anethum sowa (Shataahvaa. Shatapushpaa), Angelica archangelica himalaica (Chandaa), Bupleurum flacutum (Hare’s Ear). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 2: Quantitative documentation profile across all 42 medicinal species of family Umbelliferae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Apium graveolens follow the plant-part modalities specified under its therapeutic action (Anti-inflammatory (used in rheumatic disorders, inflammation of the urinary tract), diuretic, carminative, nervine, sedative, antiemetic, antispasmodic, antiseptic (used in bronchitis, asthma, as well as liver and spleen diseases), emmenagogue. Essential oil from seeds—tranquilizer, anticonvulsant, antifungal. Seeds are used in the treatment of chronic skin disorders including psoriasis), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Apium graveolens integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.